-
1
-
-
60749114799
-
Interindividual variability in the response to oral antiplatelet drugs; A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
-
Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R. Interindividual variability in the response to oral antiplatelet drugs; a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009;30: 426-435.
-
(2009)
Eur Heart J
, vol.30
, pp. 426-435
-
-
Kuliczkowski, W.1
Witkowski, A.2
Polonski, L.3
Watala, C.4
Filipiak, K.5
Budaj, A.6
Golanski, J.7
Sitkiewicz, D.8
Pregowski, J.9
Gorski, J.10
Zembala, M.11
Opolski, G.12
Huber, K.13
Arnesen, H.14
Kristensen, S.D.15
De Caterina, R.16
-
2
-
-
74249104162
-
Clopidogrel response status assessed with multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting
-
Sibbing D, Morath T, Braun S, Stegherr J. Clopidogrel response status assessed with multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010;103:151-159.
-
(2010)
Thromb Haemost
, vol.103
, pp. 151-159
-
-
Sibbing, D.1
Morath, T.2
Braun, S.3
Stegherr, J.4
-
3
-
-
58749090547
-
Genetic determinants of response to clopidogrel and cardiovascular events
-
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet M, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009;360: 363-375.
-
(2009)
N Engl J Med
, vol.360
, pp. 363-375
-
-
Simon, T.1
Verstuyft, C.2
Mary-Krause, M.3
Quteineh, L.4
Drouet, M.5
Méneveau, N.6
Steg, P.G.7
Ferrières, J.8
Danchin, N.9
Becquemont, L.10
-
4
-
-
77957792195
-
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: A case-control study
-
First published on 10 September 2010. doi:10.1093/eurheartj/ehq321
-
Harmsze AM, Van Werkum JW, ten Berg JM, Zwart B, Bouman HJ, Breet NJ, van 't Hoff AWJ, Ruven HJT, Hackeng CM, Klungel OH, de Boer A, Deneer VHM. CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. Eur Heart J 2010;31:3046-3053. First published on 10 September 2010. doi:10.1093/eurheartj/ehq321.
-
(2010)
Eur Heart J
, vol.31
, pp. 3046-3053
-
-
Harmsze, A.M.1
Van Werkum, J.W.2
Ten Berg, J.M.3
Zwart, B.4
Bouman, H.J.5
Breet, N.J.6
Van 'T Hoff Awj7
Hjt, R.8
Hackeng, C.M.9
Klungel, O.H.10
De Boer, A.11
Vhm, D.12
-
5
-
-
33751080762
-
Impact of P-glycoprotein on clopidogrel absorption
-
Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Schömig A, Schömig E. Impact of P-glycoprotein on clopidogrel absorption. Clin Pharmacol Ther 2006;80:486-501.
-
(2006)
Clin Pharmacol Ther
, vol.80
, pp. 486-501
-
-
Taubert, D.1
Von Beckerath, N.2
Grimberg, G.3
Lazar, A.4
Jung, N.5
Goeser, T.6
Kastrati, A.7
Schömig, A.8
Schömig, E.9
-
6
-
-
77955082077
-
Genetic variation in metabolizing enzyme and transporter genes: Comprehensive assessment in 3 major East asian subpopulations with comparison to Caucasians and Africans
-
Man M, Farmen M, Dumaual C, Teng C, Moser B, Irie S, Noh G, Njau R, Close S, Wise S, Hockett R. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol 2010;50:929-940.
-
(2010)
J Clin Pharmacol
, vol.50
, pp. 929-940
-
-
Man, M.1
Farmen, M.2
Dumaual, C.3
Teng, C.4
Moser, B.5
Irie, S.6
Noh, G.7
Njau, R.8
Close, S.9
Wise, S.10
Hockett, R.11
-
7
-
-
77955425743
-
ACCF/AHA Clopido-grel Clinical Alert: Approaches to the FDA 'Boxed Warning' A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
-
Holmes Dj, Dehmer G, Kaul S, Leifer D, O'Gara P, Stein C. ACCF/AHA Clopido-grel Clinical Alert: Approaches to the FDA 'Boxed Warning'. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation 2010;122: 537-557.
-
(2010)
Circulation
, vol.122
, pp. 537-557
-
-
Dj, H.1
Dehmer, G.2
Kaul, S.3
Leifer, D.4
O'Gara, P.5
Stein, C.6
-
8
-
-
66349133650
-
Cytochrome P450 genetic polymorphisms the response to prasugrel: Relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes
-
Mega J, Close S, Wiviott S, Shen L, Hockett R, Brandt J, Walker J, Antman E, Macias W, Braunwald E, Sabatine M. Cytochrome P450 genetic polymorphisms the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes Circulation 2009;119:2553-2560.
-
(2009)
Circulation
, vol.119
, pp. 2553-2560
-
-
Mega, J.1
Close, S.2
Wiviott, S.3
Shen, L.4
Hockett, R.5
Brandt, J.6
Walker, J.7
Antman, E.8
MacIas, W.9
Braunwald, E.10
Sabatine, M.11
-
9
-
-
58749094444
-
Cytochrome p-450 polymorphisms, response to clopidogrel
-
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms, response to clopidogrelN Engl J Med 2009;360:354-362.
-
(2009)
N Engl J Med
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Hockett, R.D.5
Brandt, J.T.6
Walker, J.R.7
Antman, E.M.8
MacIas, W.9
Braunwald, E.10
Sabatine, M.S.11
-
10
-
-
67649370752
-
Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans
-
Lee JM, Park S, Shin DJ, Choi D, Shim CY. Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans. Am J Cardiol 2009;104:46-51.
-
(2009)
Am J Cardiol
, vol.104
, pp. 46-51
-
-
Lee, J.M.1
Park, S.2
Shin, D.J.3
Choi, D.4
Shim, C.Y.5
-
11
-
-
43049179414
-
Cytochrome P450 2C19 681G.A ploymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
-
Trenk D, Hochholzer W, Fromm MF, Chialda LE, Pahl A, Valina CM, Stratz C, Schmiebusch P, Bestehorn HP, Buttner HJ, Neumann F. Cytochrome P450 2C19 681G.A ploymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 2008;51: 1925-1934.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1925-1934
-
-
Trenk, D.1
Hochholzer, W.2
Fromm, M.F.3
Chialda, L.E.4
Pahl, A.5
Valina, C.M.6
Stratz, C.7
Schmiebusch, P.8
Bestehorn, H.P.9
Buttner, H.J.10
Neumann, F.11
-
12
-
-
67649645191
-
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
-
Varenhorst C, James S, Erlinge D, Brandt JT, Braun OO, Man M, Siegbahn A, Walker JR, Wallentin L, Winters KJ, Close SL. Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. Eur Heart J 2009;30:1744-1752.
-
(2009)
Eur Heart J
, vol.30
, pp. 1744-1752
-
-
Varenhorst, C.1
James, S.2
Erlinge, D.3
Brandt, J.T.4
Braun, O.O.5
Man, M.6
Siegbahn, A.7
Walker, J.R.8
Wallentin, L.9
Winters, K.J.10
Close, S.L.11
-
13
-
-
78650326491
-
Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not prasugrel
-
Abstract 1439
-
Mega JL, Shen L, Wivion SD. Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not prasugrel. Circulation 2008;118:S325-S326 (Abstract 1439).
-
(2008)
Circulation
, vol.118
-
-
Mega, J.L.1
Shen, L.2
Wivion, S.D.3
-
14
-
-
77957262385
-
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update
-
Cuisset T, Valgimigli M, Mudra H, Muller O, Wijns W, Huber K. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update. EuroIntervention 2010;6:39-45.
-
(2010)
EuroIntervention
, vol.6
, pp. 39-45
-
-
Cuisset, T.1
Valgimigli, M.2
Mudra, H.3
Muller, O.4
Wijns, W.5
Huber, K.6
-
15
-
-
69249219296
-
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
Shuldiner AR, Bilden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 2009;302:849-857.
-
(2009)
JAMA
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
Bilden, K.P.2
Gandhi, A.3
Ryan, K.4
Horenstein, R.B.5
Damcott, C.M.6
Pakyz, R.7
Tantry, U.S.8
Gibson, Q.9
Pollin, T.I.10
Post, W.11
Parsa, A.12
Mitchell, B.D.13
Faraday, N.14
Herzog, W.15
Gurbel, P.A.16
|